The overarching goal of the Center for Cardiovascular Simulation (CCS) is developing computational biomechanical models for understanding heart valve and heart disease progression for developing clinical interventions, including prosthetics devices. We develop or utilize a range of unique in-vivo and in-vitro data for elucidating mechanisms that underlie the observed pathologies. Our modeling focus is the detailed incorporation of this data to provide a high level of physical and physiological realism and validation, working at the continuum-cellular, fibrous tissue, and whole organ levels. We ultimately seek to provide cardiovascular scientists and clinicians with advanced simulations for the rational development of treatments for structural heart and heart valve diseases. Such simulations can ultimately lead to reduction in development time, lowering of morbidity and mortality, reduced re-operative rates, and lessened post-operative recovery time. Moreover, the development and use of these tools in the context of patient-specific models will ultimately also allow clinicians to craft cardiovascular therapies that are optimized for the cardiovascular system of individuals, with a resulting increase in success and decrease in risk adverse side effects.
Michael Sacks, Director
NIH Awards $2.2 Million Grant to Dr. Michael Sacks and Research Team
Graduate Student Amir Khalighi Wins Best Poster at Frontiers in Medical Devices Conference
ICES Announces Computational Medicine Spring Seminar Series
ICES and Texas Heart Institute Collaborate with Gift and F32 Grant
Supercomputers Listen to the Heart
CCS Group photo taken June 11, 2015